Wild-type Transthyretin Amyloidosis
📧 Sign up to get email alerts when something new happens for Wild-type Transthyretin Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis
A clinical trial at a national referral center is evaluating tafamidis in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and i…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy [EARLY_Phase 1]
An early-phase clinical trial update describing peripheral and autonomic neuropathies in wild-type transthyretin amyloidosis and response to…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers
This clinical trial update describes a study on extracellular vesicles as potential disease stratifiers and prognostic biomarkers for transt…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
A Columbia University-led clinical trial is recruiting to analyze lumbar spine stenosis specimens for identification of transthyretin-relate…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause. [NA]
A clinical trial evaluating how prevalent wild-type transthyretin cardiac amyloidosis is among patients with polyneuropathy of unknown cause…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.